Discovery of SCH446211 (SCH6):  A New Ketoamide Inhibitor of the HCV NS3 Serine Protease and HCV Subgenomic RNA Replication

Stéphane Bogen, Ashok Arasappan, Frank Bennett, Kevin Chen, Edwin Jao, Yi‐Tsung Liu, Raymond G. Lovey, Srikanth Venkatraman, Weidong Pan, Tajel Parekh,

Journal of Medicinal Chemistry · 2006 · 60 citations · 15 references

DOIFull text

Open access

Concepts

Abstract

Introduction of various modified prolines at P(2) and optimization of the P(1) side chain led to the discovery of SCH6 (24, Table 2), a potent ketoamide inhibitor of the HCV NS3 serine protease. In addition to excellent enzyme potency (K(i)*= 3.8 nM), 24 was also found to be a potent inhibitor of HCV subgenomic RNA replication with IC(50) and IC(90) of 40 and 100 nM, respectively. Recently, antiviral activity of 24 was demonstrated with inhibition of the full-length genotype 2a HCV genome. In addition, 24 was found to restore the responsiveness of the interferon regulatory factor 3 (IRF-3) in cells containing HCV RNA replicons.

References

15